{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:05:09Z","timestamp":1788923109032,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T00:00:00Z","timestamp":1722643200000},"content-version":"am","delay-in-days":368,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR002553"],"award-info":[{"award-number":["UL1TR002553"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neuromodulationjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromodulation: Technology at the Neural Interface"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.neurom.2023.01.017","type":"journal-article","created":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T21:25:08Z","timestamp":1678137908000},"page":"1247-1255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Assessment of Health Care Costs and Total Baclofen Use Associated With Targeted Drug Delivery for Spasticity"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3485-4026","authenticated-orcid":false,"given":"Vishal","family":"Venkatraman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charis A.","family":"Spears","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany G.","family":"Futch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lexie Z.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth A.","family":"Parente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Jie","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivanand P.","family":"Lad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurom.2023.01.017_bib1","first-page":"111","article-title":"Epidemiological, humanistic, and economic burden of illness of lower limb spasticity in adults: a systematic review","volume":"10","author":"Martin","year":"2014","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.neurom.2023.01.017_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1615\/CritRevPhysRehabilMed.2013007945","article-title":"A\u00a0review of spasticity treatments: pharmacological and interventional approaches","volume":"25","author":"Chang","year":"2013","journal-title":"Crit Rev Phys Rehabil Med"},{"key":"10.1016\/j.neurom.2023.01.017_bib3","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/sj.sc.3101757","article-title":"Spasticity after spinal cord injury","volume":"43","author":"Adams","year":"2005","journal-title":"Spinal Cord"},{"key":"10.1016\/j.neurom.2023.01.017_bib4","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1469-8749.2011.03992.x","article-title":"Use of intrathecal baclofen therapy in ambulant children and adolescents with spasticity and dystonia of cerebral origin: a systematic review","volume":"53","author":"Pin","year":"2011","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.neurom.2023.01.017_bib5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2340\/16501977-2211","article-title":"Efficacy and safety of oral baclofen in the management of spasticity: a rationale for intrathecal baclofen","volume":"49","author":"Ertzgaard","year":"2017","journal-title":"J\u00a0Rehabil Med"},{"key":"10.1016\/j.neurom.2023.01.017_bib6","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1177\/0883073818785074","article-title":"Intrathecal baclofen therapy-practical approach: clinical benefits and complication management","volume":"33","author":"Winter","year":"2018","journal-title":"J\u00a0Child Neurol"},{"key":"10.1016\/j.neurom.2023.01.017_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/0883073807299976","article-title":"Cost-effectiveness of intrathecal baclofen therapy for the treatment of severe spasticity associated with cerebral palsy","volume":"22","author":"de Lissovoy","year":"2007","journal-title":"J\u00a0Child Neurol"},{"key":"10.1016\/j.neurom.2023.01.017_bib8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/14737167.2016.1180247","article-title":"Cost-effectiveness of intrathecal baclofen Therapy in severe refractory non-focal disabling spasticity: a Spanish Hospital perspective","volume":"17","author":"Vidal","year":"2017","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.neurom.2023.01.017_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102831","article-title":"Evaluation of the cognitive benefits of intrathecal baclofen pump implantation in people with intractable multiple sclerosis related spasticity","volume":"50","author":"Farrell","year":"2021","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.neurom.2023.01.017_bib10","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1177\/7010.2006.00134","article-title":"Oral baclofen and clonidine for treatment of spasticity in children","volume":"21","author":"Lubsch","year":"2006","journal-title":"J\u00a0Child Neurol"},{"key":"10.1016\/j.neurom.2023.01.017_bib11","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00002826-199208000-00002","article-title":"Baclofen in the treatment of dystonia","volume":"15","author":"Greene","year":"1992","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.neurom.2023.01.017_bib12","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/MLR.0000000000000326","article-title":"A\u00a0new Elixhauser-based comorbidity summary measure to predict in-hospital mortality","volume":"53","author":"Thompson","year":"2015","journal-title":"Med Care"},{"key":"10.1016\/j.neurom.2023.01.017_bib13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"10.1016\/j.neurom.2023.01.017_bib14","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/MLR.0b013e31819432e5","article-title":"A\u00a0modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data","volume":"47","author":"van Walraven","year":"2009","journal-title":"Med Care"},{"key":"10.1016\/j.neurom.2023.01.017_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.117227","article-title":"Utility of intrathecal baclofen pump in primary lateral sclerosis","volume":"420","author":"Zubair","year":"2021","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.neurom.2023.01.017_bib17","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1017\/S0317167100042244","article-title":"Intrathecal baclofen for intractable spinal spasticity--a double-blind cross-over comparison with placebo in 6 patients","volume":"19","author":"Hugenholtz","year":"1992","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.neurom.2023.01.017_bib18","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJM198906083202303","article-title":"Intrathecal baclofen for severe spinal spasticity","volume":"320","author":"Penn","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.neurom.2023.01.017_bib19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/10790268.2006.11753880","article-title":"Intrathecal baclofen toxicity and deep coma in minutes","volume":"29","author":"Tunali","year":"2006","journal-title":"J\u00a0Spinal Cord Med"},{"key":"10.1016\/j.neurom.2023.01.017_bib20","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1053\/apmr.2002.32820","article-title":"Abrupt withdrawal from intrathecal baclofen: recognition and management of a potentially life-threatening syndrome","volume":"83","author":"Coffey","year":"2002","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.neurom.2023.01.017_bib21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0003-9993(98)90021-1","article-title":"Hyperthermia, rhabdomyolysis, and disseminated intravascular coagulation associated with baclofen pump catheter failure","volume":"79","author":"Reeves","year":"1998","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.neurom.2023.01.017_bib22","first-page":"52","article-title":"Problem-solving in patients with targeted drug delivery systems","volume":"114","author":"Farid","year":"2017","journal-title":"Mo Med"},{"key":"10.1016\/j.neurom.2023.01.017_bib23","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/ner.12388","article-title":"Best practices for intrathecal baclofen therapy: dosing and long-term management","volume":"19","author":"Boster","year":"2016","journal-title":"Neuromodulation"},{"key":"10.1016\/j.neurom.2023.01.017_bib24","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/ner.12437","article-title":"Best practices for intrathecal baclofen therapy: screening test","volume":"19","author":"Boster","year":"2016","journal-title":"Neuromodulation"}],"container-title":["Neuromodulation: Technology at the Neural Interface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094715923000260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094715923000260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T12:54:24Z","timestamp":1691585664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094715923000260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1094715923000260"],"URL":"https:\/\/doi.org\/10.1016\/j.neurom.2023.01.017","relation":{},"ISSN":["1094-7159"],"issn-type":[{"value":"1094-7159","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of Health Care Costs and Total Baclofen Use Associated With Targeted Drug Delivery for Spasticity","name":"articletitle","label":"Article Title"},{"value":"Neuromodulation: Technology at the Neural Interface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurom.2023.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Neuromodulation Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}